Old Web
English
Sign In
Acemap
>
authorDetail
>
James Z. Chou
James Z. Chou
Eli Lilly and Company
Internal medicine
Endocrinology
Pharmacokinetics
Pharmacology
Medicine
4
Papers
121
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug Disposition
2016
Pharmaceutical Research
Mitchell C. Brenner
Wojciech Krzyzanski
James Z. Chou
Pierre Signore
Cyra K. Fung
David Guzman
Dongxia Li
Weihua Zhang
David R. Olsen
Viet-Tam L. Nguyen
Carolyn W. Koo
Mark D. Sternlicht
Kenneth E. Lipson
Show All
Source
Cite
Save
Citations (16)
Oral Delivery of Biologically Active Parathyroid Hormone
2001
Pharmaceutical Research
Andrea Leone-Bay
Masahiko Sato
Duncan R. Paton
Ann H. Hunt
Donald J. Sarubbi
Monica Carozza
James Z. Chou
James Patrick Mcdonough
Robert A. Baughman
Show All
Source
Cite
Save
Citations (86)
The GLP-1 analogue LY307161 is resistant to degradation by DDP-IV and is fully active in vitro
2000
Diabetes Research and Clinical Practice
Sharon R. Myers
James Z. Chou
Valerie K Williams
James Arthur Hoffmann
Show All
Source
Cite
Save
Citations (0)
A Radioimmunoassay for LY315902 an analog of Glucagon-like Insulinotropic Peptide, and Its Application in the Study of Canine Pharmacokinetics
1997
Journal of Pharmaceutical Sciences
James Z. Chou
Gary D. Place
David Waters
Jeffrey A. Kirkwood
Ronald R. Bowsher
Show All
Source
Cite
Save
Citations (19)
1